Colgate-Palmolive (NYSE:CL) Shares Bought by Empirical Finance LLC

Empirical Finance LLC grew its holdings in Colgate-Palmolive (NYSE:CL) by 2.2% during the third quarter, according to the company in its most recent filing with the SEC. The fund owned 28,845 shares of the company’s stock after acquiring an additional 632 shares during the quarter. Empirical Finance LLC’s holdings in Colgate-Palmolive were worth $2,994,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also made changes to their positions in the business. Balboa Wealth Partners acquired a new stake in shares of Colgate-Palmolive during the third quarter worth about $226,000. OneDigital Investment Advisors LLC increased its position in Colgate-Palmolive by 23.8% during the third quarter. OneDigital Investment Advisors LLC now owns 14,829 shares of the company’s stock worth $1,539,000 after buying an additional 2,847 shares during the period. Metis Global Partners LLC boosted its holdings in shares of Colgate-Palmolive by 13.1% in the third quarter. Metis Global Partners LLC now owns 28,671 shares of the company’s stock valued at $2,976,000 after acquiring an additional 3,320 shares during the period. Huntington National Bank grew its position in shares of Colgate-Palmolive by 10.3% during the third quarter. Huntington National Bank now owns 172,829 shares of the company’s stock worth $17,941,000 after acquiring an additional 16,121 shares during the last quarter. Finally, D Orazio & Associates Inc. increased its holdings in shares of Colgate-Palmolive by 3.9% in the 3rd quarter. D Orazio & Associates Inc. now owns 2,862 shares of the company’s stock valued at $297,000 after acquiring an additional 108 shares during the period. Institutional investors and hedge funds own 80.41% of the company’s stock.

Colgate-Palmolive Stock Performance

Shares of NYSE CL opened at $91.49 on Friday. The company has a debt-to-equity ratio of 9.46, a current ratio of 1.04 and a quick ratio of 0.68. The company has a market cap of $74.75 billion, a PE ratio of 26.20, a price-to-earnings-growth ratio of 3.25 and a beta of 0.42. The company has a 50-day simple moving average of $99.94 and a 200-day simple moving average of $98.48. Colgate-Palmolive has a 12 month low of $75.17 and a 12 month high of $109.30.

Colgate-Palmolive Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Friday, November 15th. Shareholders of record on Friday, October 18th will be paid a dividend of $0.50 per share. This represents a $2.00 dividend on an annualized basis and a dividend yield of 2.19%. The ex-dividend date of this dividend is Friday, October 18th. Colgate-Palmolive’s dividend payout ratio is presently 57.31%.

Insider Transactions at Colgate-Palmolive

In related news, Director Martina Hundmejean sold 2,313 shares of the company’s stock in a transaction on Friday, August 23rd. The shares were sold at an average price of $103.86, for a total transaction of $240,228.18. Following the completion of the sale, the director now directly owns 11,755 shares of the company’s stock, valued at approximately $1,220,874.30. This represents a 16.44 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CFO Stanley J. Sutula III sold 45,410 shares of the business’s stock in a transaction dated Tuesday, November 5th. The stock was sold at an average price of $94.11, for a total value of $4,273,535.10. Following the transaction, the chief financial officer now owns 36,726 shares in the company, valued at approximately $3,456,283.86. This represents a 55.29 % decrease in their position. The disclosure for this sale can be found here. Insiders own 0.34% of the company’s stock.

Analyst Ratings Changes

A number of research firms have commented on CL. Redburn Atlantic upgraded shares of Colgate-Palmolive to a “hold” rating in a research note on Thursday, August 1st. Hsbc Global Res downgraded Colgate-Palmolive from a “strong-buy” rating to a “hold” rating in a research note on Friday, July 26th. Deutsche Bank Aktiengesellschaft downgraded Colgate-Palmolive from a “buy” rating to a “hold” rating and increased their price target for the stock from $107.00 to $109.00 in a report on Monday, September 9th. Barclays raised their target price on shares of Colgate-Palmolive from $91.00 to $96.00 and gave the stock an “equal weight” rating in a research note on Monday, July 29th. Finally, JPMorgan Chase & Co. increased their price target on shares of Colgate-Palmolive from $113.00 to $114.00 and gave the stock an “overweight” rating in a report on Friday, October 11th. One investment analyst has rated the stock with a sell rating, nine have given a hold rating and thirteen have given a buy rating to the company’s stock. Based on data from MarketBeat, the company has an average rating of “Moderate Buy” and a consensus price target of $105.11.

Colgate-Palmolive Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.